Location: Home
  • search
  • go
  • Relate News
  • 11/17/2022CDE Solicits Comments on the Technical Guidelines for Clinical Researc...
  • 11/17/2022Mirati Therapeutics Sues China's InventisBio for CNY 99M in Trade Sec...
  • 11/17/2022Marinus Pharma and Tenacia Biotech Tie Up for Ganaxolone Development ...
  • 11/17/2022IPF Presents Big Opportunities and Challenges for China Drugmakers
  • 11/17/2022Growing Pains: Charting The Rapid Rise Of Chinese IO (In Vivo - Pharma...
  • 11/16/2022Kinarus Therapeutics Engages Great Health Companion Group to Explore P...
  • 11/16/2022CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...
  • 11/16/2022CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...
  • 11/16/2022NHC Reorganizes Medical Administration Departments to Emphasize Epidem...
  • 11/16/2022Harbour Biomed Launches Nona Biosciences to Provide "Ideas to IND" Pre...
  • 11/16/2022CDE Issues the Measures for Suspension and Resumption of Review Timing...
  • 11/15/2022NMPA Holds Conference on Promotion of Foreign Trade and Investment
  • 11/15/2022Biotheus and Hansoh Strike Licensing Deal for its EGFR/MET Bispecific ...
  • 11/15/2022Simcere and Idorsia Enter into a Licensing Agreement for Daridorexant ...
  • 11/15/2022WuXi Vaccines Buys Harbour BioMed China Facility
  • 11/15/2022Highlights on the New Drug Recall Regulation of 2022 (Mondaq)
  • 11/14/2022Fire Sale! China's "Warren Buffett" Races To Sell Assets (Forbes)
  • 11/14/2022Surging Beigene Catches Case of Forex Flu (The Bamboo Works)
  • 11/14/2022Fundraising Continued to Drop in October, No Drugmaker Raised More Tha...
  • 11/14/2022Cyagen, Neurophth Ink $140 Million Deal For AI-Designed AAV Capsids
  • 11/14/2022CDE Issues the Technical Guidelines for Clinical R&D of Bispecific Ant...
  • 11/14/2022BioNTech and Fosun Pharma Receive Special Approvals for Omicron-BA.4/B...
  • 11/14/2022Snapshot of BMI System Financial Performance in 3Qs/2022
  • 11/11/2022CDE Issues the Work Procedures for Changes During Drug Registration Ap...
  • 11/11/2022NMPA Announces Package Insert Revision of Phloroglucinol Injection
  • 11/11/2022AstraZeneca Launches First Alexion Rare Disease Therapy for Patients i...
  • 11/11/2022NMPA Solicits Comments on the Special Rules for TCM Registration
  • 11/11/2022Harbour BioMed Enters into a License and Collaboration Agreement with ...
  • 11/11/2022Drug R&D and Product Registration News Digest November 2022 (2)
  • 11/11/2022Review of A Share-listed Chinese MedPharm Cos in Q3/2022
  • Page:122/775 Total number of articles:23243: [First][<<] [120] [121] [122] [123] [124] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group